Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia

Topics in Stroke Rehabilitation

Volumn 13, Issue 4, 2006, Pages 74-85

  Francisco, Gerard E ^a,b   Yablon, Stuart A ^c,d   Schiess, Mya C ^a,e   Wiggs, Laura ^b   Cavalier, Steven ^f   Grissom, Samuel ^g,h  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TIRR MEMORIAL HERMANN   (United States)

^c Department of Neurology ^*  (United States)

^d METHODIST REHABILITATION CENTER   (United States)

^e MEMORIAL HERMANN HOSPITAL   (United States)

^f NeuroMedical Center   (United States)

^g RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^h KESSLER INSTITUTE FOR REHABILITATION   (United States)

Author keywords

Baclofen; Intrathecal therapy; Spasticity; Stroke

Indexed keywords

BACLOFEN;

ANTICOAGULATION; CATHETERIZATION; CLINICAL PROTOCOL; CONSENSUS; DEFORMITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENDURANCE; HUMAN; INTESTINAL DYSMOTILITY; MEDICAL DECISION MAKING; MOTOR DYSFUNCTION; MUSCLE HYPERTONIA; NEUROGENIC BLADDER; OUTCOMES RESEARCH; PATIENT CARE; PATIENT SELECTION; PRACTICE GUIDELINE; RATING SCALE; REVIEW; RISK ASSESSMENT; SEIZURE; SEXUAL FUNCTION; SPASTIC HYPERTONIA; SPASTICITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

BACLOFEN; CEREBROVASCULAR ACCIDENT; HUMANS; INJECTIONS, SPINAL; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PRACTICE GUIDELINES;

EID: 33750982714     PISSN: 10749357     EISSN: None     Source Type: Journal    
DOI: 10.1310/tsr1304-74     Document Type: Review

References (37)

1. Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM. Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch Phys Med Rehabil. 2001;82(9):1155-1163.
2. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996;46(5):1306-1310.
3. Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347(6):395-400.
4. Meythaler JM, Guin-Renfroe S, Hadley MN. Continually infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil. 1999;78(3):247-254.
5. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke. 2001;32(9):2099-2109.
6. Francisco GE, Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch Phys Med Rehabil. 2003;84(8):1194-1199.
7. Remy-Neris O, Tiffreau V, Bouilland S, Bussel B. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehabil. 2003;84(5):643-650.
8. Horn TS, Yablon SA, Stokic DS. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil. 2005;86(6):1127-1133.
9. Schiess MC, Acosta F, Izor R, Fischer S, Furr E, Simpson R. Functional motor control improvement after intrathecal baclofen pump therapy in stroke related spastic hemiplegia. Neural Repair. 2006;66(5 suppl 2).
10. Francisco GE, Ivanhoe CB, Grissom SP, et al. Prospective evaluation of the efficacy and safety of intrathecal baclofen therapy for spastic hypertonia due to stroke. Arch Phys Med Rehabil. 2001;82:1341.
11. Edlund W, Gronseth G, So Y, Franklin G. Clinical Practice Guideline Process Manual. American Academy of Neurology. 2004. Available at: http://www.aan.com/professionals/practice/pdfs/2004_Guideline_Process.pdf.
12. Perry J, Garrett M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke. 1995;26(6):982-989.
13. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. 1986;379(1):104-111.
14. Brailowsky S, Knight RT, Blood K, Scabini D. Gamma-Aminobutyric acid-induced potentiation of cortical hemiplegia. Brain Res. 1986;362(2):322-330.
15. Goldstein LB. Potential effects of common drugs on stoke recovery. Arch Neurol. 1998;55(4):454-456.
16. Hornby TG, Heckman CJ, Harvey RL, Rymer WZ. Changes in voluntary torque and electromyographic activity following oral baclofen. Muscle Nerve. 2004;30(6):784-795.
17. Ada L, Vattanasilp W, O'Dwyer NJ, Crosbie J. Does spasticity contribute to walking dysfunction after stroke? J Neurol Neurosurg Psychiatry. 1998;64(5):628-635.
18. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540-542.
19. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206-207.
20. Armon C, Evans RW. Addendum to assessment: prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65(4):510-512.
21. Kofler M, Kronenberg MF, Rifici C, Saltuari L, Bauer G. Epileptic seizures associated with intrathecal baclofen application. Neurology. 1994;44(1):25-27.
22. Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology. 2005;64(6):1086-1087.
23. Kofler M, Matzak H, Saltuari L. The impact of intrathecal baclofen on gastrointestinal function. Brain Inj. 2002;16(9):825-836.
24. Frost F, Nanninga J, Penn R, Savoy S, Wu Y. Intrathecal baclofen infusion. Effect on bladder management programs in patients with myelopathy. Am J Phys Med Rehabil. 1989;68(3):112-115.
25. Nanninga JB, Frost F, Penn R. Effect of intrathecal baclofen on bladder and sphincter function. J Urol. 1989;142(1):101-105.
26. Denys P, Mane M, Azouvi P, Chartier-Kastler E, Thiebaut JB, Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil. 1998;79(5):494-496.
27. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Molinoff PB, Buddon RW, Gilman AG, eds. The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996:557-580.
28. Akman MN, Loubser PG, Donovan WH, O'Neill ME, Rossi CD. Intrathecal baclofen: Does tolerance occur? Paraplegia. 1993;31(8):516-520.
29. Neilsen JF, Hansen HJ, Sunde N, Chrisensen JJ. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin Neurol Neurosurg. 2002;104(2):142-145.
30. Soni BM, Mani RM, Oo T, Vaidyanathan S. Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance - a case report and review of literature. Spinal Cord. 2003;41(10):586-589.
31. Yablon SA, Hayes A, Stokic DS. The utility of the h-reflex for monitoring the delivery of continuous intrathecal baclofen (CITB) in patients with dysfunctional spasticity. Dose adjustment and troubleshooting. Neurorehabil Neural Repair. 2001;15:328.
32. Stokic DS, Yablon SA. Neurophysiological basis and clinical applications of the h-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity. Neurochir Suppl. In press.
33. Lew SM, Psaty EL, Abbott R. An unusual cause of overdose after baclofen pump implantation: case report. Neurosurgery. 2005;56(3):E624.
34. Dawes WJ, Drake JM, Fehlings D. Microfracture of a baclofen pump cathether with intermittent under- and overdose. Pediatr Neurosurg. 2003;39(3):144-148.
35. Schurch B. Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report. Paraplegia. 1993;31(9):611-615.
36. Grabb PA, Guin-Renfroe S, Meythaler JM. Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadri-paretic spasticity. Neurosurgery. 1999;45(4):833-836.
37. Chappuis DM, Boortz-Marx RL, Stuckey MW, et al. Safety of continuously infused intrathecal baclofen in the cervical and high thoracic areas for patients with spasticity, dystonia, and movement disorders: a prospective case series. Arch Phys Med Rehabil. 2002;83:7676.